Actively Recruiting

Age: 18Years +
All Genders
NCT05966467

Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies

Led by Alexion Pharmaceuticals, Inc. · Updated on 2026-02-10

122

Participants Needed

33

Research Sites

317 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Long-term, multicenter, multinational, observational, registry of patients with AQP4+ NMOSD that is designed to collect data on clinical outcomes and safety in patients prescribed Alexion C5 inhibitor therapies (C5IT). The registry will also collect data on patient reported outcomes (PROs), quality of life (QoL), and targeted AQP4+ NMOSD therapies used to provide evidence on the real-world impact of ALXN-C5IT on patients with AQP4+ NMOSD.

CONDITIONS

Official Title

Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participant is 18 years of age or older at enrollment.
  • Confirmed diagnosis of AQP4+ NMOSD.
  • Receiving treatment with ALXN-C5IT for chronic relapse prevention according to local label.
  • Received at least one dose of eculizumab within 4 weeks prior to enrollment or at least one dose of ravulizumab within 12 weeks prior to enrollment.
  • Available historical data on ALXN-C5IT dosing since start and relapse number and types from 1 year before ALXN-C5IT initiation through enrollment.
Not Eligible

You will not qualify if you...

  • Currently enrolled in an interventional clinical study for AQP4+ NMOSD treatment involving a drug.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 33 locations

1

Clinical Trial Site

Washington D.C., District of Columbia, United States, 20010

Actively Recruiting

2

Research Site

Boston, Massachusetts, United States, 02114

Actively Recruiting

3

Clinical Trial Site

Chapel Hill, North Carolina, United States, 27599

Not Yet Recruiting

4

Clinical Trial Site

Columbus, Ohio, United States, 43215

Actively Recruiting

5

Clinical Trial Site

Plano, Texas, United States, 75024

Actively Recruiting

6

Clinical Trial Site

Milwaukee, Wisconsin, United States, 53215

Actively Recruiting

7

Clinical Trial Site

Buenos Aires, Argentina

Actively Recruiting

8

Clinical Trial Site

Buenos Aires, Argentina

Not Yet Recruiting

9

Clinical Trial Site

Buenos Aires, Argentina

Actively Recruiting

10

Clinical Trial Site

Buenos Aires, Argentina

Actively Recruiting

11

Clinical Trial Site

Burnaby, British Columbia, Canada

Actively Recruiting

12

Clinical Trial Site

Beijing, China

Not Yet Recruiting

13

Clinical Trial Site

Guangzhou, China

Not Yet Recruiting

14

Clinical Trial Site

Henan, China

Not Yet Recruiting

15

Clinical Trial Site

Shanghai, China

Not Yet Recruiting

16

Clinical Trial Site

Sichuan, China

Not Yet Recruiting

17

Clinical Trial Site

Wuhan, China

Not Yet Recruiting

18

Clinical Trial Site

Dresden, Germany

Actively Recruiting

19

Clinical Trial Site

Essen, Germany

Actively Recruiting

20

Clinical Trial Site

München, Germany

Not Yet Recruiting

21

Clinical Trial Site

Naples, Italy

Actively Recruiting

22

Clinical Trial Site

Fukuoka, Japan

Actively Recruiting

23

Clinical Trial Site

Kawasaki, Japan

Actively Recruiting

24

Clinical Trial Site

Miyagi, Japan

Actively Recruiting

25

Clinical Trial Site

Tokyo, Japan

Not Yet Recruiting

26

Clinical Trial Site

Daejeon, South Korea

Actively Recruiting

27

Clinical Trial Site

Gyeonggi-do, South Korea

Actively Recruiting

28

Clinical Trial Site

Seoul, South Korea

Actively Recruiting

29

Clinical Trial Site

Seoul, South Korea

Actively Recruiting

30

Clinical Trial Site

Seoul, South Korea

Actively Recruiting

31

Clinical Trial Site

Seoul, South Korea

Actively Recruiting

32

Clinical Trial Site

Seoul, South Korea

Actively Recruiting

33

Clinical Trial Site

Seoul, South Korea

Actively Recruiting

Loading map...

Research Team

A

Alexion Pharmaceuticals, Inc. (Sponsor)

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here